Protocol RTOG 0938

RADIATION THERAPY ONCOLOGY GROUP
RTOG 0938
A RANDOMIZED PHASE II TRIAL OF HYPOFRACTIONATED RADIOTHERAPY FOR FAVORABLE RISK PROSTATE CANCER

Protocol Participation Information

Facility Questionnaire: Part I and Part II are required for this protocol.
- Download fillable forms and complete them.
- Submit to RTOG RT Quality Assurance Department
  Email: rtog-facquest@phila.acr.org Fax: 215-940-8817
IGRT Immobilization/Localization Systems Test
- IGRT Credentialing for RTOG Protocols
- Submitting IGRT Data to the ITC
- Anonymized Patient Spreadsheet to be submitted with IGRT patient data (updated 4/2011)
RPC Phantom Dosimetry Test (Prostate Phantom)

Fill out the RPC Phantom Request Form to request shipment of a phantom.
Contact Bill Straube at ITC (314-362-9762, itc@wustl.edu) regarding submission of phantom treatment planning data to the ITC.

If a CyberKnife unit is to be used to treat patients on the RTOG 0938 protocol, the institution must have treated at least two previous prostate patients with CyberKnife and meet all other credentialing requirements prior to enrolling a CyberKnife treated prostate patient onto this protocol.

In order to be credentialed for use of proton therapy on this protocol, insitutions must (1) submit a Facility Questionnaire, (2) successfully complete an RPC Site Visit, (3) obtain an ITC SFTP account and successfully transfer a proton treatment plan in digital format to the ITC, and (4) successfully complete the RTOG IGRT Immobilization/Localization Test.
ATC Guidelines for the Use of Protons in NCI Cooperative Group Trials (4/12/2012)

Please contact Bill Straube at ITC (314-362-9762, itc@wustl.edu) for instructions.

Back to protocols